Listed by the USPTO as WEDDINGTON, KEVIN E
Tech Center 1600 • Art Units: 1613 1614 1621 1629 1644
This examiner grants 75% of resolved cases
WEDDINGTON, KEVIN E is assigned to art unit 1613 in tech center 1600. The record contains 1476 resolved cases, with an allowance rate of 75.3% and a median of 903 days to allowance. The interview lift is 9.8%, indicating a modest positive association. Counsel may therefore use interviews selectively while giving primary attention to claim quality and written responses.
The leading companies are Antecip Bioventures Ii LLC, Mindset Pharma Inc., and Baxter Healthcare S.A. The leading firms are COOLEY LLP, ICE MILLER LLP, and Baker, Donelson, Bearman, Caldwell & Berkowitz, PC. The extensive record provides a substantial basis for understanding prosecution patterns in this art unit.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18683842 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Non-Final OA | Mindset Pharma Inc. |
| 18217821 | LIPID EMULSIONS FOR PARENTERAL NUTRITION | Non-Final OA | BAXTER HEALTHCARE SA |
| 18700358 | IMIDAZO[1,2-A]PYRIDINE DERIVATIVES | Non-Final OA | SYNGENTA CROP PROTECTION AG |
| 18043436 | N-Linked Glycosylation Inhibitors and Methods of Using Same | Non-Final OA | YALE UNIVERSITY |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy75.3% of resolved applications examined by Kevin E Weddington were allowed (1,476 resolved cases), compared with 34.0% across Art Unit 1613 over the last five years.
This examiner's interview lift is +9.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Kevin E Weddington took 903 days on average from filing to allowance.
Kevin E Weddington examines applications in Art Unit 1613 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
